Citation Impact
1 by Nobel laureates 5 from Science/Nature 64 standout
Citing Papers
A Phase 2 Randomized Trial of Survodutide in MASH and Fibrosis
2024 Standout
Triple hormone receptor agonist retatrutide for metabolic dysfunction-associated steatotic liver disease: a randomized phase 2a trial
2024 Standout
Works of David E. Watson being referenced
Evaluation of Efficacy and Safety of the Glucagon Receptor Antagonist LY2409021 in Patients With Type 2 Diabetes: 12- and 24-Week Phase 2 Studies
2015
A novel high-sensitivity electrochemiluminescence (ECL) sandwich immunoassay for the specific quantitative measurement of plasma glucagon
2012
Author Peers
| Author | CCM | Molecular Biology | Oncology | EDM | Surgery | Last Decade | Papers | Cites |
|---|---|---|---|---|---|---|---|---|
| David E. Watson | 62 | 265 | 58 | 170 | 153 | 22 | 745 | |
| U. Myler | 2 | 4 | 21 | 475 | ||||
| Silvana Sale | 3 | 25 | 16 | 1 | 10 | 16 | 338 | |
| Xiang Fu | 2 | 35 | 303 | |||||
| Andrzej Jakubowski | 122 | 164 | 53 | 14 | 58 | 21 | 555 | |
| Martha R. Szczur | 10 | 12 | 1 | 11 | 251 |
All Works
Login with ORCID to disown or claim papers
Loading papers...